¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"international unit of enzyme activity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • intensive care unit
    ÁßȯÀÚ½Ç, ÁýÁßÄ¡·á½Ç
  • motor unit
    ¿îµ¿´ÜÀ§
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
  • pilosebaceous unit
    ÅÐÇÇÁö»ù´ÜÀ§
  • plaque-forming unit
    ÇöóÅ©Çü¼º´ÜÀ§
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§
  • peripheral resistance unit
    ¸»ÃÊÀúÇ×´ÜÀ§
  • repeating unit
    ¹Ýº¹¼­¿­´ÜÀ§
  • respiratory care unit
    ÁßÁõÈ£ÈíÁýÁßÄ¡·áº´µ¿
  • roentgen unit
    ·ÛÆ®°Õ´ÜÀ§
  • suction unit
    ÈíÀÎÀåÄ¡
  • unit
    1. ´ÜÀ§ 2. ±â, ÀåÄ¡
  • unit membrane
    ´ÜÀ§¸·
  • angiotensin converting enzyme
    ¾ØÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • fertility unit
    °¡ÀÓ´ÜÀ§
  • focus forming unit
    ¹ÙÀÌ·¯½ºÆ÷Ä¿½ºÇü¼º´ÜÀ§
  • motor unit fraction
    ¿îµ¿´ÜÀ§ºÐȹ
  • hypothermia unit
    Àúü¿ÂÀåÄ¡
  • infectious unit
    °¨¿°À¯¹ß·®´ÜÀ§
  • intensive care unit
    ÁßȯÀÚ½Ç
  • intermittent traction unit
    °£Çæ°ßÀÎÀåÄ¡
  • maximum security unit
    ÃÖ´ë¾ÈÀüº´µ¿
  • megavoltage unit
    Ãʰí¾Ð¹æ»ç¼±ÀåÄ¡
  • motor unit
    ¿îµ¿´ÜÀ§
  • myopathic motor unit
    ±ÙÀ°º´¿îµ¿´ÜÀ§ÀüÀ§
  • trilaminar unit membrane
    ¼¼Ãþ´ÜÀ§¸·
  • unit membrane
    ´ÜÀ§¸·
  • operational taxonomic unit
    Á¶ÀÛ»óºÐ·ù´ÜÀ§
  • orthovoltage unit
    °ü¿ëÀü¾Ð¿¢½º¼±ÀåÄ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • heterogeneous enzyme immunoassay
    ºÒ±ÕÀÏ<--Áú>È¿¼Ò¸é¿ªÇÐÀûÃøÁ¤(¹ý)
  • homogeneous enzyme immunoassay
    ±ÕÁúÈ¿¼Ò¸é¿ªÃøÁ¤(¹ý)
  • induced enzyme
    À¯µµÈ¿¼Ò.
  • inducible enzyme
    À¯µµ(¹ß)È¿¼Ò.
  • inducible enzyme
    À¯¹ß°¡´ÉÈ¿¼Ò
  • inhibitory enzyme
    ÀúÇØÈ¿¼Ò.
  • inorganic enzyme
    ¹«±âÈ¿¼Ò(ÙíѦý£áÈ).
  • phosphorylating enzyme
    ÀλêÈ­È¿¼Ò(ìÝß« ûùý£áÈ).
  • prosthetic group-labeled enzyme
    º¸Á¶±ºÇ¥ÁöÈ¿¼Ò
  • rate limiting enzyme
    ¼ÓµµÁ¶ÀýÈ¿¼Ò(áÜöôðàï½ý£áÈ).
  • receptor destroying enzyme
    ¼ö¿ëüÆÄ±«È¿¼Ò(¡­÷òÎÕý£áÈ).
  • redox enzyme
    »êȭȯ¿øÈ¿¼Ò(ß«ûùü»êªý£áÈ).
  • reducing enzyme
    ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
  • regulatory enzyme
    Á¶ÀýÈ¿¼Ò(¡­ý£áÈ).
  • CPU (central processing unit)
    Áß¾Ó Ã³¸® ÀåÄ¡
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • partial agonistic activity
    ºÎºÐÈ¿´É(Àû) Ȱ¼º, ºÎºÐÈ¿Çö(Àû) Ȱ¼º.
  • phagocytic activity
    ½Ä¼¼Æ÷´É(¡­Òö).
  • plasma histaminase activity
    Ç÷ÀåÈ÷½ºÅ¸¹Ì³ª¾ÆÁ¦È°¼ºµµ.
  • plasma renin activity
    Ç÷Àå·¹´ÑȰ¼ºµµ<--Ȱµ¿µµ>
  • psychomotor activity
    Á¤½Å¿îµ¿¼º Ȱµ¿.
  • realtive sepcific activity
    »ó´ëºñ¹æ»ç´É
  • redirection activity
    ¹æÇ⺯°æÈ°µ¿
  • repetitious activity
    ¹Ýº¹Àû Ȱµ¿
  • ristocetin co-factor activity
    ¸®½ºÅ似ƾº¸Á¶ÀÎÀÚȰ¼ºµµ
  • saturated activity
    Æ÷È­¹æ»ç´É
  • social welfare activity
    »çȸº¹Áö»ç¾÷(ÊÙËÓ̤ Ë×Ëâ).
  • specific activity
    ƯÀÌȰ¼º[µµ], ºñ[Ýï]Ȱ¼º[µµ]
  • specific activity
    ºñ¹æ»ç´É
  • sperm activity grade test
    Á¤Àڿ¼ºµµ °Ë»ç¹ý
  • structure activity relationship
    ±¸Á¶-Ȱ¼ºµµ°ü°è.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • unit cell
    ´ÜÀ§(Ó¤êÈ) ¼¼Æ÷ (á¬øà)
  • unit evolutionary period
    ´ÜÀ§(Ó¤êÈ) ÁøÈ­±â°£ (òäûùÑ¢Êà)
  • unit mass
    ´ÜÀ§(Ó¤êÈ) Áú·®(òõÕá)
  • unit membrane hypothesis
    ´ÜÀ§¸·¼³(Ó¤êÈØ¯àã)
  • unit mitochondrion hypothesis
    ´ÜÀ§(Ó¤êÈ) ¹ÌÅäÄܵ帮¾Æ¼³(àã)
  • activating enzyme
    "ºÎȰȿ¼Ò (Ý·üÀý£áÈ), Ȱ¼ºÈ­È¿¼Ò (üÀàõûùý£áÈ)"
  • acyl activating enzyme
    ¾Æ½ÇºÎȰȿ¼Ò (Ý·üÀý£áÈ)
  • acyl enzyme
    ¾Æ½ÇÈ¿¼Ò(ý£áÈ)
  • acyl enzyme intermediates
    ¾Æ½ÇÈ¿¼Ò Áß°£Ã¼(ñéÊàô÷)
  • adaptive enzyme
    ÀûÀÀÈ¿¼Ò(îêëëý£áÈ)
  • alteration enzyme
    º¯ÇüÈ¿¼Ò(ܨúþý£áÈ)
  • ambiquitous enzyme
    ¾çÁ¸È¿¼Ò(å»ðíý£áÈ)
  • amino acid activating enzyme
    ¾Æ¹Ì³ë»ê(ß«) Ȱ¼ºÈ­(üÀàõûù) È¿¼Ò(ý£áÈ)
  • amplifier enzyme
    ÁõÆøÈ¿¼Ò(ñòøëý£áÈ)
  • analogous enzyme variants
    À¯»çÈ¿¼Ò º¯ÀÌÇü(×¾ÞÄý£áÈܨì¶úþ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PACE Pacing and Clinical Electrophysiology; paired basic amino acid cleaving enzyme; personalized aerobic...
ICD I-cell disease; immune complex disease; implantable cardioverter defibrillator; impulse-control diso...
IPA immunoperoxidase assay; incontinentia pigmenti achromians; independent physician or practice associa...
IU   1) International Unit; ±¹Á¦´ÜÀ§
  2) Immunizing Unit; ¸é¿ª´ÜÀ§
IOU intensive care observation unit; international opacity unit
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ICD 10 International Classification of Disease
ICD-9 International Classification of Disease 9
ICD-O International Classification of Disease for Oncology
ICD-9 International Classification of Disease, 9th Revision
ICD9CM International Classification of Diseases 9th Revision Clinical Modification
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • maximum security unit
    ÃÖ´ë ¾ÈÀü º´µ¿
  • mouse unit
    ¸¶¿ì½º ´ÜÀ§
  • neuromuscular unit
    ½Å°æ±Ù ´ÜÀ§
  • operational unit
    ÀÛ¿ë ´ÜÀ§
  • pepsin unit
    Æé½Å ´ÜÀ§
    À§¾× ÁßÀÇ Æé½ÅÀ» Á¤·®ÇÏ´Â µ¥ ¾²ÀÌ´Â ´ÜÀ§.
  • peripheral resistance unit
    ¸»ÃÊ ÀúÇ× ´ÜÀ§
  • pilosebaceous unit
    ºÎ¼Ó ±â°ü
  • plaque forming unit
    ÇöóÅ© Çü¼º ´ÜÀ§
  • plating unit
    µµ±Ý±â
    Àü±â µµ±Ý½ÃŰ´Â ±â±¸.
  • portable X-ray unit
    À̵¿ X¼± ÀåÄ¡
  • pulse control unit
    ¸Æ¹Ú Á¶Àý ´ÜÀ§
  • radiation unit
    ¹æ»ç¼± ´ÜÀ§
  • resonance unit
    °ø¸í ´ÜÀ§
  • roentgen unit
    X¼± ´ÜÀ§, ·ÛÆ®°Õ ´ÜÀ§
  • self care unit
    ÀÚ°¡ °ü¸® Åõ¼®
    ½º½º·Î Ç÷¾× Åõ¼®À» ÇÏ´Â ½Ã½ºÅÛ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
angiotensin-converting enzyme inhibitor <pharmacology> A class of drugs used in the treatment of hypertension and heart failure.
They exert their haemodynamic effect mainly by inhibiting the renin-angiotensin system and produce a reduction of peripheral arterial resistance. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
(14 Aug 2000)
angiotensin-converting enzyme secretase <enzyme> Converts ace from a membrane-bound to a soluble form; not inhibited by thiol, serine or acid enzyme inhibitor but is inhibited by edta and 1,10-phenanthroline
Registry number: EC 3.4.99.-
Synonym: ace secretase
(26 Jun 1999)
Antibody Directed Enzyme Prodrug Therapy <pharmacology> A method for targeting a drug to a specific tissue, in which the targeting agent and the drug are administered separately.
The drug is designed to be inactive (a prodrug) until it is converted by an enzyme, which is the targeting agent. The enzyme is coupled to an antibody that directs it to the tissue of interest. When the enzyme arrives at the tissue, the prodrug is activated only at that site, sparing other tissues from potentially toxic side effects.
Acronym: ADEPT
(14 Nov 1997)
antitumour enzyme <enzyme> An enzyme that stimulates the degradation of a particular metabolite that cannot be synthesised by tumour cells, inhibits the synthesis of a metabolite needed by tumour cells, or inhibits tumour-specific DNA utilization; e.g., asparaginase.
(05 Mar 2000)
autolytic enzyme <enzyme> An enzyme capable of causing lysis of the cell forming it.
(05 Mar 2000)
beta-carotene cleavage enzyme <enzyme> An enzyme catalyzing the reaction of beta-carotene plus O2 producing two retinals.
Synonym: beta-carotene cleavage enzyme, carotenase, carotinase.
(05 Mar 2000)
branching enzyme 1,4-alpha-d-glucan branching enzyme
cardiac enzyme <biochemistry> A group of enzymes found normally in heart tissue. Cardiac enzymes are released into the blood stream in increased concentration when the heart muscle becomes damaged.
Examples include SGOT, CPK-MB and LDH.
(27 Sep 1997)
pancreatic enzyme <biochemistry> One of the proteins made by the pancreas that aid digestion of fats, carbohydrates and proteins.
(09 Oct 1997)
malate-condensing enzyme <enzyme> An important enzyme in the glyoxylic acid cycle which reversibly catalyses the synthesis of l-malate from acetyl-CoA and glyoxylate.
Chemical name: L-Malate glyoxylate-lyase (CoA-acetylating)
Registry number: EC 4.1.3.2
(12 Dec 1998)
malic enzyme <enzyme> An enzyme that catalyses the conversion of (s)-malate and NAD+ to oxaloacetate and NADH.
Chemical name: (S)-Malate:NAD+ oxidoreductase
Registry number: EC 1.1.1.37
(12 Dec 1998)
pantoate-activating enzyme pantothenate synthetase
marker enzyme <enzyme> An enzyme that is used to identify a specific cell type, cell organelle, or cell component.
(05 Mar 2000)
reducing enzyme <enzyme> An enzyme that catalyses a reduction; since all enzymes catalyze reactions in either direction, any reductase can, under the proper conditions, behave as an oxidase and vice versa, hence the term oxidoreductase. For individual reductase's, see the specific names.
Synonym: reducing enzyme.
(05 Mar 2000)
regulatory enzyme <biochemistry> An enzyme that regulatescertain functions due to its ability to undergoa change in its catalytic activity through modification of its structure.
(09 Oct 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • International Atomic Energy Agency
    (UNÀÇ)±¹Á¦ ¿øÀڷ±ⱸ(IAEA)
  • International Bank for Reconstruction and Development
    ±¹Á¦ ºÎÈï°³¹ßÀºÇà(IBRD)ÅëĪ(the world bank)
  • International Chamber of Commerce
    ±¹Á¦ »ó¾÷ȸÀǼÒ(ICC)
  • International Civil Aviation Organization
    (UNÀÇ)±¹Á¦ ¹Î°£Ç×°ø±â±¸(ICAO)
  • International Code
    (¼±¹ÚµîÀÇ)±¹Á¦ ±â ½ÅÈ£;±¹Á¦ Àü½ÅºÎÈ£
  • International Committee of the Red Cross
    Àû½ÊÀÚ ±¹Á¦ À§¿øÈ¸(ICRC)
  • International Court of Justice
    ±¹Á¦ »ç¹ý ÀçÆÇ¼Ò(ICJ)
  • International Criminal Police Organization
    INTERPOL
  • International Date Line
    ±¹Á¦ ³¯Â¥ º¯°æ¼±(IDL)
  • International Development Association
    (UNÀÇ)±¹Á¦ °³¹ß Çùȸ(IDA)
  • International Energy Agency
    ±¹Á¦ ¿¡³ÊÁö ±â±¸(IEA)
  • International Film Festival
    ±¹Á¦¿µÈ­Á¦(IFF)
  • International Geophysical Year
    ±¹Á¦ Áö±¸ °üÃø³â(IGY)
  • International Institute for Strategic Studies
    (¿µ)±¹Á¦ Àü·«¿¬±¸¼Ò(I.I.S.S)
  • International Labor Organization
    ±¹Á¦ ³ëµ¿ ±â±¸(ILO)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á